Brain-derived neurotrophic factor inducing angiogenesis through modulation of matrix-degrading proteases

Chinese Medical Journal

Volumn 119, Issue 7, 2006, Pages 589-595

  Sun, Chun Yan ^a   Hu, Yu ^a   Wang, Hua Fang ^a   He, Wen Juan ^a   Wang, Ya Dan ^a   Wu, Tao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiogenesis; Brain derived neurotrophic factor; Extracellular proteolytic enzyme

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UROKINASE;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; UMBILICAL VEIN; WESTERN BLOTTING; ZYMOGRAPHY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PHYSIOLOGIC; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; URINARY PLASMINOGEN ACTIVATOR;

EID: 33646847895     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200604010-00013     Document Type: Article

References (25)

1. Kumar S, Witzig TE, Timm M, Hang J, Welli KL, Fonseca R. Expression of VEGF and its receptors by myeloma cells. Leukemia 2003;17:2025-2031.
2. Jakson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 1997;11:457-465.
3. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674.
4. Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 1997;22:251-256.
5. Hu Y, Sun CY, Wang YD, Wei WN, Wu T, He WJ, et al. Study on the high expression of brain-derived neurotrophic factor in multiple myeloma patients and its possible mechanism. J Exp Hematol (Chin) 2005;13: 104-109.
6. Kim H, Li Q, Hempstead BL, Madri JA. Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells. J Bio Chem 2004;279:33538-33546.
7. Pepper MS, Montesano E, Mandriota SJ, Orci L, Vassalli JD. Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphognesis. Enzyme Protein 1996;49:138-162.
8. Demeule M, Brossard M, Page M, Gingras D, Beliveau R. Matrix metalloproteinase inhibition by green tea catechins. Biochim Biophys Acta 2000;1478:51-60.
9. Vacca A, Ribatti D, Lurlaro M, Aibinl A, Minischetti M, Bussolino F, et al. Human lymphoblastoid cells produces extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res 1998;28:55-68.
10. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-2756.
11. Kim YM, Lee YM, Kim HS, Kim JD, Choi Y, Kim KW, et al. TNF-related activation-induced cytokine (TRANCE) Induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J Biol Chem 2002;277:6799-6805.
12. Noga O, Hanf G, Schaper C, O'Connor A, Kunkel G. The influence of inhalative corticosteroids on circulating nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in allergic asthmatics. Clin Exp Allergy 2001;31:1906-1912.
13. Botchkarev VA. Neurotrophins and their role in pathogenesis of alopecia areata. J Investig Dermatol Symp Proc 2003;8:195-198.
14. Aoyama M, Asai K, Shishikura T, Kawamoto T, Miyachi T, Yokoi T, et al. Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett 2001;164:51-60.
15. Kowalski PJ, Paulino AF. Perineural invasion in adenoid cystic carcinoma: Its causation/promotion by brain-derived neurotrophic factor. Hum Pathol 2002;33:933-936.
16. Pepper MS. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 2001;21:1104-1117.
17. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494.
18. Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WF, et al. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998;75:780-786.
19. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA, et al. Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 1994; 162:499-511.
20. Zucker S, Conner C, DiMassimo BI, Ende H, Draws M, Drews M, et al. Thrombin induces the activation of progelatinase A in vascular endothelial cells: physiologic regulation of angiogenesis. J Biol Chem 1995;270: 23730-23738.
21. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-336.
22. Anteby EY, Greenfield C, Natanson-Yaron S, Goldman-Wohl D, Hamani Y, Khudyak V, et al. Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9. Mol Hum Reprod 2004;10:229-235.
23. Rabbani SA, Mazar AP. The role of the plasminogen activation system in angiogenesis and metastasis. Surg Oncol Clin N Am 2001;10:393-415.
24. Kumar R, Yoneda J, Bucana CD, Fidler IJ. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int J Oncol 1998;12:749-757.
25. Unlu A, Leake RE. Transforming growth factor beta1 stimulates urokinase plasminogen activator system on prostate cancer cells. Int J Biol Markers 2003;18:147-151.